• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

观察性流行病学研究的高效设计评估

Evaluation of efficient designs for observational epidemiologic studies.

作者信息

Kalish L A, Begg C B

出版信息

Biometrics. 1987 Mar;43(1):145-67.

PMID:3567303
Abstract

Recent research in the design of observational epidemiologic studies has been focused on determining which design is most efficient for controlling a potential confounding factor in the analysis of the disease-exposure relationship. Typically, only two candidate designs have been considered, the matched design and the random sample design. These are merely two of an infinite variety of potential designs in which the distributions of the confounder in the comparison groups and the ratio of group sample sizes are arbitrarily chosen. Only in special cases will either of the standard designs be the most efficient or "optimal" design. We construct optimal designs by minimizing the variance of the desired estimate of effect with respect to the controllable design parameters. Construction of an optimal design depends on unknown parameters, so that in practice only an approximately optimal design, perhaps constructed sequentially, is possible. We evaluate the potential usefulness of optimal designs by identifying circumstances in which an optimal design results in large efficiency gains relative to both the matched and random sample designs. We find that there can be substantial efficiency gains in follow-up studies when both the exposure and confounder are strong risk factors. Practical issues in the implementation of these designs are discussed.

摘要

近期关于观察性流行病学研究设计的研究主要集中在确定哪种设计在分析疾病-暴露关系时最有效地控制潜在混杂因素。通常,仅考虑了两种候选设计,即匹配设计和随机抽样设计。这些仅仅是无穷多种潜在设计中的两种,其中比较组中混杂因素的分布以及组样本量的比例是任意选择的。只有在特殊情况下,标准设计中的任何一种才会是最有效或“最优”的设计。我们通过相对于可控设计参数最小化所需效应估计值的方差来构建最优设计。最优设计的构建依赖于未知参数,因此在实践中,可能只能构建一个近似最优设计,或许是按顺序构建。我们通过确定相对于匹配设计和随机抽样设计,最优设计能带来大幅效率提升的情况,来评估最优设计的潜在实用性。我们发现,当暴露因素和混杂因素都是强风险因素时,随访研究中可以有显著的效率提升。还讨论了实施这些设计的实际问题。

相似文献

1
Evaluation of efficient designs for observational epidemiologic studies.观察性流行病学研究的高效设计评估
Biometrics. 1987 Mar;43(1):145-67.
2
Matching in epidemiologic studies: validity and efficiency considerations.流行病学研究中的匹配:有效性和效率考量
Biometrics. 1981 Jun;37(2):271-91.
3
Epidemiologic studies: pitfalls in interpretation.流行病学研究:解读中的陷阱。
Dialogues Contracept. 1995 Winter;4(5):5-6, 8.
4
On design considerations and randomization-based inference for community intervention trials.关于社区干预试验的设计考量及基于随机化的推断
Stat Med. 1996 Jun 15;15(11):1069-92. doi: 10.1002/(SICI)1097-0258(19960615)15:11<1069::AID-SIM220>3.0.CO;2-Q.
5
Issues in the planning and conduct of non-randomised studies.非随机研究的规划与实施中的问题。
Injury. 2006 Apr;37(4):340-8. doi: 10.1016/j.injury.2006.01.026. Epub 2006 Feb 17.
6
Statistical methods for epidemiologic studies of the health effects of air pollution.空气污染对健康影响的流行病学研究中的统计方法。
Res Rep Health Eff Inst. 1999 May(86):1-50; discussion 51-6.
7
Optimal designs of two-stage studies for estimation of sensitivity, specificity and positive predictive value.用于估计敏感性、特异性和阳性预测值的两阶段研究的最优设计
Stat Med. 2002 Dec 15;21(23):3609-25. doi: 10.1002/sim.1318.
8
Designing studies to estimate the penetrance of an identified autosomal dominant mutation: cohort, case-control, and genotyped-proband designs.设计研究以估计已识别的常染色体显性突变的外显率:队列研究、病例对照研究和基因分型先证者设计。
Genet Epidemiol. 1999;16(1):15-39. doi: 10.1002/(SICI)1098-2272(1999)16:1<15::AID-GEPI3>3.0.CO;2-8.
9
The effect of dropout on the efficiency of D-optimal designs of linear mixed models.缺失值对线性混合模型D - 最优设计效率的影响。
Stat Med. 2008 Jun 30;27(14):2601-17. doi: 10.1002/sim.3108.
10
Efficient two-sample designs for microarray experiments with biological replications.用于具有生物学重复的微阵列实验的高效双样本设计。
In Silico Biol. 2004;4(4):461-70.

引用本文的文献

1
Living donor liver transplantation for Barcelona clinic liver cancer (BCLC) intermediate-stage hepatocellular carcinoma.活体供肝肝移植治疗巴塞罗那临床肝癌(BCLC)中期肝细胞癌。
Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):169-182. doi: 10.21037/hbsn-21-196. Epub 2022 Mar 11.